Pharmaceutical Drugs Policy and Legislation Science; Research & Innovations Tuberculosis (TB)
There is hope for people living with multi-drug resistant tuberculosis (MDR-TB) as the “gruelling” two-year treatment with “terrible side-effects” such as deafness can now be successfully shortened to just nine months.
Almost 25 percent of health facilities surveyed nationally have gone without HIV or tuberculosis (TB) medicines at least once in the last year, according to preliminary survey results released this week.
Dozens of activists and patients picketed today outside the Johannesburg meeting of a United Nations high level panel on access to medicines. Activists have demanded governments fund more drug research and development.
The United Nations Secretary-General’s High-Level Panel on Access to Medicines is calling for proposals to enhance and strengthen the promotion of innovation and access to medicines, vaccines and diagnostics.